Global Hepatitis Testing Diagnosis Market Growth 2025-2031

The global Hepatitis Testing Diagnosis market size is predicted to grow from US$ 3888 million in 2025 to US$ 5547 million in 2031; it is expected to grow at a CAGR of 6.1% from 2025 to 2031.

The purpose of hepatitis tests is to screen for and diagnose hepatitis, evaluate the liver, and to determine the underlying cause of hepatitis

Common hepatitis tests include Enzyme-linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests (RDT), Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), etc.

United States market for Hepatitis Testing Diagnosis is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Hepatitis Testing Diagnosis is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Hepatitis Testing Diagnosis is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Hepatitis Testing Diagnosis players cover F. Hoffmann-La Roche, Abbott Laboratories, Siemens Healthineers AG, Bio-Rad Laboratories, Danaher Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Hepatitis Testing Diagnosis Industry Forecast” looks at past sales and reviews total world Hepatitis Testing Diagnosis sales in 2024, providing a comprehensive analysis by region and market sector of projected Hepatitis Testing Diagnosis sales for 2025 through 2031. With Hepatitis Testing Diagnosis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hepatitis Testing Diagnosis industry.

This Insight Report provides a comprehensive analysis of the global Hepatitis Testing Diagnosis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hepatitis Testing Diagnosis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hepatitis Testing Diagnosis market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hepatitis Testing Diagnosis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hepatitis Testing Diagnosis.

This report presents a comprehensive overview, market shares, and growth opportunities of Hepatitis Testing Diagnosis market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Enzyme-linked Immunosorbent Assay (ELISA)
Rapid Diagnostic Tests (RDT)
Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
Others

Segmentation by Application:
Hospital
Blood Banks
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
F. Hoffmann-La Roche
Abbott Laboratories
Siemens Healthineers AG
Bio-Rad Laboratories
Danaher Corporation
QIAGEN
BioMerieux SA
DiaSorin S.P.A.
Ortho Clinical Diagnostics
MedMira Inc
Fujirebio
Grifols
Orasure Technologies
GenMark Diagnostics
Vela Diagnostics
Epitope Diagnostics
Trivitron Healthcare
Meril Life Sciences
geneOmbio Technologies
Molbio Diagnostics

Key Questions Addressed in this Report

What is the 10-year outlook for the global Hepatitis Testing Diagnosis market?

What factors are driving Hepatitis Testing Diagnosis market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Hepatitis Testing Diagnosis market opportunities vary by end market size?

How does Hepatitis Testing Diagnosis break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.